CUTR News and Press, Cutera Inc. From 09/19/23

2023-09-19 10:55:02 ET Summary Cutera's FY 2023 revenue guidance suggests that the company's top line is expected to contract on both a YoY and HoH (Half-on-Half) basis in the second half of this year. On the flip side, a new CEO was appointed in August, and his recent share purch...

The Secret by Cutera ® portfolio expands with the first combination 1540 nm laser and radio frequency microneedling technology available in the US. CUTERA, INC. (Nasdaq: CUTR) a global leader in aesthetic and dermatology solutions, today announces the launch of Secret DUO, ...

Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that on August 17,2023 the Compensation Committee of Cutera’s Board of Directors approved the grant of inducement awards to Jeffre...

2023-08-30 12:00:25 ET Cutera ( NASDAQ: CUTR ) shares shot up 18% in midday trading Wednesday after its CEO and interim CFO bought around $346K in company stock. Shares of Cutera recently sold for $11.78 at around 11:30 a.m. ET after hitting a high of $11.81. According to SE...

2023-08-24 10:30:54 ET Summary INMD's P/E and EV/EBITDA ratios have fallen sharply in the past 2-3 years despite its revenues and net income more than doubling in this period. The prospect of continued profitable growth and a history of beating analysts' estimates suggest that thi...

2023-08-24 09:38:54 ET Cutera ( NASDAQ: CUTR ) appoints Jeff Jones as chief operating officer, effective August 28, 2023. Mr. Jones will report directly to Taylor Harris, Cutera’s CEO, and will be responsible for end-to-end operations, including manufac...

Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, is pleased to announce the appointment of Jeff Jones as Chief Operating Officer, effective August 28, 2023. This move underscores Cutera’s commitm...

2023-08-14 13:30:00 ET Summary After making a new 2023 high on July 31, the market is now in the process of consolidating its gains and expanding its participation. The Death Cross ended on February 2, 2023. We are now in a Golden Cross configuration, with the 50-day above the 200...

2023-08-09 10:08:11 ET Gainers: Tango Therapeutics ( TNGX ) +137% . Decibel Therapeutics ( DBTX ) +72% . Mirati Therapeutics ( MRTX ) +26% . Azenta ( AZTA ) +25% . Clover Health Investments ( CLOV ) +18 % . Losers: ...

2023-08-08 23:53:07 ET Cutera, Inc. (CUTR) Q2 2023 Earnings Call Transcript August 08, 2023 04:30 PM ET Company Participants Sheila Hopkins - Former Interim Chief Executive Officer Stuart Drummond - Interim Chief Financial Officer Taylor Harris - Chief Executive ...